Forecasting individual progression trajectories in Huntington disease enables more powered clinical trials

por Koval, Igor, Dighiero-Brecht, Thomas, Tobin, Allan J., Tabrizi, Sarah J., Scahill, Rachael I., Tezenas du Montcel, Sophie, Durrleman, Stanley, Durr, Alexandra
Publicado 2022

Comprehensive Behavioral Testing in the R6/2 Mouse Model of Huntington's Disease Shows No Benefit from CoQ10 or Minocycline

por Menalled, Liliana B., Patry, Monica, Ragland, Natalie, Lowden, Phillip A. S., Goodman, Jennifer, Minnich, Jennie, Zahasky, Benjamin, Park, Larry, Leeds, Janet, Howland, David, Signer, Ethan, Tobin, Allan J., Brunner, Daniela
Publicado 2010